Delha Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 08-12-2024
- Paid Up Capital ₹ 1.10 M
as on 08-12-2024
- Company Age 4 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.50 M
as on 08-12-2024
- Revenue 68.35%
(FY 2022)
- Profit 92.92%
(FY 2022)
- Ebitda 62.52%
(FY 2022)
- Net Worth 33.20%
(FY 2022)
- Total Assets 88.14%
(FY 2022)
About Delha Pharmaceuticals
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.10 M.
The company currently has active open charges totaling ₹2.50 M.
Jandhyala Lakshmi and Madhu Jandhyala serve as directors at the Company.
- CIN/LLPIN
U24232AP2020PTC114373
- Company No.
114373
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Mar 2020
- Date of AGM
28 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Krishna, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Delha Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jandhyala Lakshmi  | Director | 16-Mar-2020 | Current |
| Madhu Jandhyala | Director | 07-Mar-2022 | Current |
Financial Performance of Delha Pharmaceuticals.
Delha Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 68.35% increase. The company also saw a substantial improvement in profitability, with a 92.92% increase in profit. The company's net worth Soared by an impressive increase of 33.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Delha Pharmaceuticals?
Unlock access to Delha Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 08 Jul 2020 | ₹2.50 M | Open |
How Many Employees Work at Delha Pharmaceuticals?
Delha Pharmaceuticals has a workforce of 2 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Delha Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Delha Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
